中国神经再生研究(英文版) ›› 2020, Vol. 15 ›› Issue (3): 557-568.doi: 10.4103/1673-5374.266066

• 原著:脑损伤修复保护与再生 • 上一篇    

营养因子对移植少突胶质祖细胞存活和围产期兴奋性氨基酸毒性的神经保护至关重要

  

  • 出版日期:2020-03-15 发布日期:2020-05-26
  • 基金资助:
    NIH和NICHD资助

Trophic factors are essential for the survival of grafted oligodendrocyte progenitors and for neuroprotection after perinatal excitotoxicity

Megumi Hirose-Ikeda1, Brian Chu1, Paul Zhao1, Omar Akil1, Elida Escalante1, Laurent Vergnes2, Carlos Cepeda1, Araceli Espinosa-Jeffrey1   

  1. 1 Intellectual and Developmental Disabilities Research Center, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Departments of Neurobiology, Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, CA, USA  2 Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
  • Online:2020-03-15 Published:2020-05-26
  • Contact: Carlos Cepeda, PhD, IDDRC,ccepeda@mednet.ucla.edu.
  • Supported by:
    The Cell Culture Core supported by grant No. PP1498: Neural Cell Culture Core and NIH grant No. 04612 Intellectual & Developmental Disabilities. The Cell, Circuits and Systems Analysis Core is supported by NICHD award No. U54HD087101-03.

摘要:

早产、低体重分娩和产妇产前感染是导致脑性瘫痪和认知障碍新生儿脑白质损伤的最常见原因。在发育期大脑中,少突胶质细胞成熟发生在围产期,而未成熟的少突胶质细胞特别容易受到伤害,作者先前报道了转铁蛋白和胰岛素生长因子1对内源性神经祖细胞的特化和动员。为了解少突胶质祖细胞移植到受兴奋毒性损伤小鼠脑实质中是否可以拯救脑白质损伤。实验给予 4日龄小鼠单独脑实质内注射谷氨酸受体激动剂N-甲基-D-天冬氨酸或与转铁蛋白和胰岛素生长因子1联合,结合或不结合少突胶质祖细胞移植于大脑实质中。实验发现单独移植的少突胶质祖细胞不能在兴奋毒性环境中存活;而当与转铁蛋白和胰岛素生长因子1联合应用时,移植的少突胶质祖细胞则可存活。此外,少突胶质祖细胞的能量代谢被N-甲基-D-天冬氨酸提高,但受转铁蛋白和胰岛素生长因子1调节。大脑中响应于N-甲基-D-天冬氨酸的泛素化和应激/热休克蛋白90升高,在转铁蛋白和胰岛素生长因子1存在下这些变化被逆转,且泛素化减少。该实验结果表明,使用营养因子与少突胶质祖细胞移植的组合干预有利于少突胶质祖细胞移植于兴奋性氨基酸毒性脑组织后的长期存活,并整合于大脑中。

orcid: 0000-0001-5953-6692 (Carlos Cepeda)

关键词: 早产, 脑室周围白质软化, 髓鞘形成, 少突胶质细胞, 白质损伤, 髓鞘再生, 蛋白质组学, 营养因子

Abstract: The consequences of neonatal white matter injury are devastating and represent a major societal problem as currently there is no cure. Prematurity, low weight birth and maternal pre-natal infection are the most frequent causes of acquired myelin deficiency in the human neonate leading to cerebral palsy and cognitive impairment. In the developing brain, oligodendrocyte (OL) maturation occurs perinatally, and immature OLs are particularly vulnerable. Cell replacement therapy is often considered a viable option to replace progenitors that die due to glutamate excitotoxicity. We previously reported directed specification and mobilization of endogenous committed and uncommitted neural progenitors by the combination of transferrin and insulin growth factor 1 (TSC1). Here, considering cell replacement and integration as therapeutic goals, we examined if OL progenitors (OLPs) grafted into the brain parenchyma of mice that were subjected to an excitotoxic insult could rescue white matter injury. For that purpose, we used a well-established model of glutamate excitotoxic injury. Four-day-old mice received a single intraparenchymal injection of the glutamate receptor agonist N-methyl-D-aspartate alone or in conjunction with TSC1 in the presence or absence of OLPs grafted into the brain parenchyma. Energetics and expression of stress proteins and OL developmental specific markers were examined. A comparison of the proteomic profile per treatment was also ascertained. We found that OLPs did not survive in the excitotoxic environment when grafted alone. In contrast, when combined with TSC1, survival and integration of grafted OLPs was observed. Further, energy metabolism in OLPs was significantly increased by N-methyl-D-aspartate and modulated by TSC1. The proteomic profile after the various treatments showed elevated ubiquitination and stress/heat shock protein 90 in response to N-methyl-D-aspartate. These changes were reversed in the presence of TSC1 and ubiquitination was decreased. The results obtained in this pre-clinical study indicate that the use of a combinatorial intervention including both trophic support and healthy OLPs constitutes a promising approach for long-term survival and successful graft integration. We established optimal conditioning of the host brain environment to promote long-term survival and integration of grafted OLPs into an inflamed neonate host brain. Experimental procedures were performed under the United States Public Health Service Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care Committee at (UCLA) (ARC #1992-034-61) on July 1, 2010.

Key words: myelin regeneration, myelination, oligodendrocytes, periventricular leukomalacia, premature birth, proteomics, trophic factors, white matter injury